Canadian National Railway Shares Soar On Q2 Performance, Clocks 21% Revenue Growth
Canadian National Railway (NYSE:CNI) reported a second-quarter revenue increase of 21% year-over-year to C$4.34 billion. Adjusted EPS improved by 30%…
Why Teva Pharmaceuticals Stock Is Soaring After Hours
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.
Luxfer Holdings Q2 EPS $0.35 Beats $0.33 Estimate, Sales $109.50M Beat $106.40M Estimate
Luxfer Holdings (NYSE:LXFR) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.33 by 6.06 percent. This is a 2.78 percent decrease over earnings of $0.36 per share from the
Avangrid Q2 EPS $0.48 Beats $0.34 Estimate
Avangrid (NYSE:AGR) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.34 by 41.18 percent. This is a 37.14 percent increase over earnings of $0.35 per share from the same
Visa Shares Are Moving After Hours: What’s Going On?
Visa Inc (NYSE: V) shares are volatile in Tuesday's after-hours session after the company reported its
Ashland Global Holdings Q3 EPS $1.89 Beats $1.67 Estimate, Sales $644.00M Beat $622.79M Estimate
Ashland Global Holdings (NYSE:ASH) reported quarterly earnings of $1.89 per share which beat the analyst consensus estimate of $1.67 by 13.17 percent. This is a 54.92 percent increase over earnings of $1.22 per share
NextGen Healthcare Q1 EPS $0.16, Inline, Sales $153.30M Beat $152.90M Estimate
NextGen Healthcare (NASDAQ:NXGN) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 36 percent decrease over earnings of $0.25 per share from the same period last year.
Teradyne Q2 EPS $1.21 Beats $1.14 Estimate, Sales $841.00M Beat $829.13M Estimate
Teradyne (NASDAQ:TER) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.14 by 6.14 percent. This is a 36.65 percent decrease over earnings of $1.91 per share from the same
Teva Pharmaceutical Indus Q2 EPS $0.68 Beats $0.57 Estimate, Sales $3.80B Beat $3.78B Estimate
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.57 by 19.3 percent. This is a 15.25 percent increase over earnings of $0.59 per share
Pzena Investment Mgmt Q2 EPS $0.15 Down From $0.25 YoY, Sales $52.76M Up From $50.88M YoY
Pzena Investment Mgmt (NYSE:PZN) reported quarterly earnings of $0.15 per share. This is a 40 percent decrease over earnings of $0.25 per share from the same period last year. The company reported $52.76 million in